Lexicon Pharmaceuticals (LXRX) PT Raised to $0.85 at Jefferies
Tweet Send to a Friend
Jefferies analyst Andrew Tsai raised the price target on Lexicon Pharmaceuticals (NASDAQ: LXRX) to $0.85 (from $0.70) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
